Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 1621

Summary: An estimated 13.6% of deaths in the U.S could be attributed to dementia. The number is 2.7 times higher than the official reported dementia-related deaths. The underestimation varies greatly by race, with 7.1 times more older Black adults, and 4.1 times more Hispanic adults, dying from dementia that public records indicate.

Source: boston university school of medicine.

Dementia may be an underlying cause of nearly three times more deaths in the U.S. than official records show, according to a new Boston University School of Public Health (BUSPH) study.

Read more | >

Genetic variants may contribute to increased levels of antibodies against proteins of the Epstein-Barr virus — a known environmental risk factor for multiple sclerosis (MS) — in MS patients and their siblings, a study suggests.

The study, “EBNA-1 titer gradient in families with multiple sclerosis indicates a genetic contribution,” was published in the journal Neurology, Neuroimmunology and Neuroinflammation.

Read more | >

Our muscles start to shrink and weaken when we reach our 50s and 60s in a process called sarcopenia, but new research in mice from the University of Michigan offers new insights into why this loss may occur, and how we might begin to prevent it.

Sarcopenia is the progressive loss of mass in aging, and it’s linked to other age-related pathologies such as osteoarthritis, cardiovascular disease and cancer, as well as an overall reduction in function and independence.

The research, led by Carlos Aguilar, a U-M assistant professor of biomedical engineering, focused on since they are dedicated solely to keeping muscles healthy. And to better understand stem cell function during aging, testing was conducted on two sets of mice, one “young” and one “old,” before and after muscle injury.

Read more | >

Researchers have designed a simple, low-cost device for subcutaneous injection of viscous formulations.

MIT researchers have developed a simple, low-cost technology to administer powerful drug formulations that are too viscous to be injected using conventional medical syringes.

The technology, which is described in a paper published today in the journal Advanced Healthcare Materials, makes it possible to inject high-concentration drugs and other therapies subcutaneously. It was developed as a solution for highly effective, and extremely concentrated, biopharmaceuticals, or biologics, which typically are diluted and injected intravenously.

Read more | >

“you can rest easy. The asteroid does not pose a threat to life on Earth. Most likely, it will sail harmlessly past our planet. At worst, it will burn up harmlessly in our atmosphere and create a firework show for some lucky Earthlings.” 🤔.

Social media around the world lit up over the weekend, discussing the possibility that an asteroid (known as 2018 VP₁) could crash into Earth on November 2.

It seemed only fitting. What better way to round off a year that has seen catastrophic floods, explosions, fires, and storms—and, of course, a global pandemic?

Continue reading “Asteroid 2018 VP₁ may be heading for Earth. But there’s no need to worry” | >

Federal, state and local authorities continue to investigate a multistate outbreak of Salmonella Enteritidis infections linked to peaches as new retailers are added to the related recall list.

All of the implicated peaches were packed or supplied by Prima Wawona or Wawona Packing Co., both of California.

The Centers for Disease Control and Prevention reports that epidemiologic evidence indicates peaches are the likely source of this outbreak. As of Aug. 19, the CDC reported a total of 68 confirmed patients across nine states. The Food and Drug Administration’s investigation to identify a source of contamination is ongoing.

Read more | >